Critical Contributions of CRM1 to Leukemogenesis |
University of Vermont / Jessica Linda Heath, MD |
Young Investigator Grants |
2015 |
Vermont |
Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors |
University of Florida / Catherine Flores, PhD |
Young Investigator Grants |
2015 |
Florida |
Engager T Cells: A Novel Immunotherapeutic for AML |
University of Michigan / Challice Bonifant, MD, PhD |
Young Investigator Grants |
2015 |
Michigan |
The Cebpa Downstream Enhancer as a Key Target of Transformation to Acute Myeloid Leukemia |
The Johns Hopkins University School of Medicine / Stacy Cooper, MD |
Young Investigator Grants |
2015 |
Maryland |
Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma |
University of California San Francisco / Ozlem Aksoy, PhD |
Young Investigator Grants |
2015 |
California |
Novel Nanoscale Phosphoproteomic Discovery of Therapeutic Targets in AML Stem Cells |
Dana-Farber Cancer Institute / Leo Wang, MD, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia |
University of California San Francisco / Elliot Stieglitz, MD |
Young Investigator Grants |
2015 |
California |
Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer
Directed Therapy
|
Dana-Farber Cancer Institute / Andrew Hong, MD |
Young Investigator Grants |
2015 |
Massachusetts |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Genetic Dissection of Cancer Drug Resistance and Toxicity Using Haploid Human Cells |
Stanford University / Ramin Dubey, PhD |
Young Investigator Grants |
2015 |
California |